Table 1

Adjusted negative binomial regression models for the effect of different levels of smoke exposure on rate of acute chest syndrome (ACS) and pain episodes in adults with SCD

VariableModel 1: Effect of active smoking on the rates of ACS and pain events compared with those with no smoke exposure
Model 2: Effect of passive smoking on the rates of ACS and pain events compared with those with no smoke exposure
RR (95% CI)PRR (95% CI)P
ACS*     
    Active smoking 2.61 (1.24-5.51) .01   
    Environmental tobacco smoke exposure only   2.62 (1.05-6.57) .04 
Pain     
    Active smoking 1.94 (1.04-3.62) .04   
    Environmental tobacco smoke exposure only   1.59 (0.74-3.43) .24 
VariableModel 1: Effect of active smoking on the rates of ACS and pain events compared with those with no smoke exposure
Model 2: Effect of passive smoking on the rates of ACS and pain events compared with those with no smoke exposure
RR (95% CI)PRR (95% CI)P
ACS*     
    Active smoking 2.61 (1.24-5.51) .01   
    Environmental tobacco smoke exposure only   2.62 (1.05-6.57) .04 
Pain     
    Active smoking 1.94 (1.04-3.62) .04   
    Environmental tobacco smoke exposure only   1.59 (0.74-3.43) .24 

ACS indicates acute chest syndrome; SCD, sickle cell disease; RR, relative risk; and CI, confidence interval.

*

Multivariable models of ACS were adjusted for SCD phenotype (HbSS/HbSβthal° vs others), age, hemoglobin, white blood cell count, history of asthma, hydroxyurea use.3,7 

Multivariable models of pain were adjusted for SCD phenotype, age, sex, hemoglobin, history of asthma, hydroxyurea use.7,8 

or Create an Account

Close Modal
Close Modal